✦ LIBER ✦

Efficacy of a Transient Receptor Potential Vanilloid 1 Antagonist (AZD1386) in Human Esophageal Pain: A Two-Centre, Randomized, Placebo-Controlled, Cross-Over Study

✍ Scribed by Anne L. Krarup; Lars Ny; Magnus Åstrand; Antal Bajor; Frederk Hvid-Jensen; Mark Berner Hansen; Magnus Simren; Peter Funch-Jensen; Asbjørn M. Drewes

Book ID: 119432117
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 380 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60269-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: the efficacy

Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain

✍ A. L. Krarup; L. Ny; M. Åstrand; A. Bajor; F. Hvid-Jensen; M. B. Hansen; M. Simr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

✍ Albany, C.; Brames, M. J.; Fausel, C.; Johnson, C. S.; Picus, J.; Einhorn, L. H. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB